Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.19%38.36B | 4.92%36.91B | 10.85%140.63B | 6.13%34.39B | 9.12%35.27B | 13.26%35.79B | 15.18%35.18B | 16.00%126.86B | 18.02%32.41B | 14.76%32.32B |
Cost of revenue | 6.42%15.46B | 0.91%14.36B | 8.33%56.44B | 2.01%13.27B | 5.46%14.42B | 11.54%14.52B | 14.76%14.23B | 15.64%52.09B | 15.11%13.01B | 17.63%13.67B |
Gross profit | 7.71%22.9B | 7.64%22.55B | 12.60%84.19B | 8.90%21.13B | 11.80%20.85B | 14.46%21.26B | 15.47%20.95B | 16.25%74.77B | 20.04%19.4B | 12.75%18.65B |
Operating expense | 4.06%20.15B | 4.18%19.57B | 7.06%76.86B | 5.90%19.56B | 5.92%19.15B | 7.17%19.37B | 9.39%18.78B | 8.63%71.8B | 8.54%18.47B | 8.35%18.08B |
Staff costs | ---- | ---- | 9.96%29.8B | ---- | ---- | ---- | ---- | 10.86%27.1B | ---- | ---- |
Selling and administrative expenses | ---- | ---- | -4.57%3.76B | ---- | ---- | ---- | ---- | 35.81%3.94B | ---- | ---- |
-General and administrative expense | ---- | ---- | -4.57%3.76B | ---- | ---- | ---- | ---- | 35.81%3.94B | ---- | ---- |
Rent and land expenses | ---- | ---- | 1.55%17.02B | ---- | ---- | ---- | ---- | 4.86%16.76B | ---- | ---- |
Other operating expenses | ---- | ---- | 9.54%26.3B | ---- | ---- | ---- | ---- | 5.41%24.01B | ---- | ---- |
Operating profit | 45.04%2.75B | 37.61%2.98B | 146.42%7.33B | 68.61%1.56B | 198.07%1.7B | 276.54%1.89B | 122.94%2.17B | 267.12%2.97B | 208.04%927M | 491.10%571M |
Net non-operating interest income (expenses) | -1M | -100.00%-2M | -200.00%-3M | 50.00%-1M | 0.00%-1M | 0 | -1M | -133.33%-1M | -300.00%-2M | -200.00%-1M |
Non-operating interest income | 25.00%5M | 0.00%3M | 0.00%14M | 0.00%4M | 0.00%3M | 0.00%4M | 0.00%3M | -12.50%14M | 0.00%4M | 0.00%3M |
Non-operating interest expense | 50.00%6M | 25.00%5M | 13.33%17M | -16.67%5M | 0.00%4M | 100.00%4M | 33.33%4M | 15.38%15M | 100.00%6M | 100.00%4M |
Net investment income | -217.86%-132M | 44.44%91M | -26.09%289M | 480.00%58M | 133.33%56M | -23.29%112M | -70.14%63M | 122.16%391M | -84.85%10M | -47.83%24M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 45M | 0 | 0 | 0 | ||||||
Income from associates and other participating interests | -60.00%-8M | 0.00%-5M | -171.43%-19M | -300.00%-4M | -25.00%-5M | -400.00%-5M | -400.00%-5M | 66.67%-7M | -125.00%-1M | 50.00%-4M |
Special income (charges) | -366.67%-14M | -56.76%192M | -153.31%-298M | 23.92%-668M | -212.70%-71M | -100.32%-3M | -0.67%444M | -88.61%559M | 11.31%-878M | -97.36%63M |
Less:Other special charges | -5.26%-20M | 55.71%-221M | 68.44%-580M | 72.49%-52M | 94.90%-10M | 98.10%-19M | -9.91%-499M | 77.18%-1.84B | 90.84%-189M | 91.83%-196M |
Less:Write off | 54.55%34M | -47.27%29M | -31.35%878M | -32.52%720M | -39.10%81M | -69.44%22M | 685.71%55M | -59.35%1.28B | -65.06%1.07B | 786.67%133M |
Other non-operating income (expenses) | -3.70%26M | 9.68%34M | -1.77%111M | -45.24%23M | -9.09%30M | 125.00%27M | 19.23%31M | -22.60%113M | -25.00%42M | 0.00%33M |
Income before tax | 29.28%2.62B | 22.01%3.29B | 85.07%7.45B | 922.11%971M | 155.31%1.75B | 27.60%2.03B | 62.98%2.7B | 17.42%4.03B | 105.51%95M | -70.21%687M |
Income tax | 95.43%770M | 34.52%904M | 240.04%1.91B | 212.85%439M | 62.40%406M | 18.32%394M | 82.61%672M | -74.08%562M | -157.37%-389M | -64.89%250M |
Net income | 13.24%1.85B | 17.92%2.39B | 59.94%5.54B | 9.71%531M | 208.70%1.35B | 30.06%1.63B | 57.42%2.03B | 174.76%3.46B | 120.16%484M | -72.58%437M |
Net income continuous operations | 13.30%1.85B | 17.86%2.39B | 59.92%5.54B | 9.92%532M | 208.47%1.35B | 30.06%1.63B | 57.38%2.03B | 174.84%3.46B | 120.16%484M | -72.58%437M |
Noncontrolling interests | -27.27%8M | -9.09%10M | 40.63%45M | 22.22%11M | 20.00%12M | 22.22%11M | 175.00%11M | -15.79%32M | -10.00%9M | 0.00%10M |
Net income attributable to the company | 13.39%1.84B | 18.12%2.38B | 60.13%5.49B | 9.49%519M | 213.11%1.34B | 30.10%1.62B | 57.10%2.01B | 180.84%3.43B | 119.65%474M | -73.04%427M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 13.39%1.84B | 18.12%2.38B | 60.13%5.49B | 9.49%519M | 213.11%1.34B | 30.10%1.62B | 57.10%2.01B | 180.84%3.43B | 119.65%474M | -73.04%427M |
Gross dividend payment | ||||||||||
Basic earnings per share | 13.88%41.93 | 19.16%54.3 | 61.02%124.89 | 11.38%11.94 | 216.68%30.56 | 30.66%36.82 | 57.08%45.57 | 180.71%77.56 | 119.65%10.72 | -73.07%9.65 |
Diluted earnings per share | 13.85%41.9213 | 19.16%54.3 | 61.02%124.89 | 10.50%11.8444 | 216.32%30.525 | 30.66%36.82 | 57.08%45.57 | 180.71%77.56 | 119.65%10.7193 | -73.06%9.65 |
Dividend per share | 15.00%23 | 0 | 33.33%40 | 25.00%20 | 0 | 42.86%20 | 0 | 15.38%30 | 14.29%16 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |